These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2266473)

  • 41. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array.
    Haigh O; Depelsenaire AC; Meliga SC; Yukiko SR; McMillan NA; Frazer IH; Kendall MA
    J Control Release; 2014 Nov; 194():148-56. PubMed ID: 25192942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Light and electron microscopic findings in human epidermis reconstructed in vitro upon topical application of liposomal tretinoin.
    Schaller M; Steinle R; Korting HC
    Acta Derm Venereol; 1997 Mar; 77(2):122-6. PubMed ID: 9111822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of argan oil and phospholipids for the development of an effective liposome-like formulation able to improve skin hydration and allantoin dermal delivery.
    Manca ML; Matricardi P; Cencetti C; Peris JE; Melis V; Carbone C; Escribano E; Zaru M; Fadda AM; Manconi M
    Int J Pharm; 2016 May; 505(1-2):204-11. PubMed ID: 27063848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stability of a liposomal formulation containing lipoyl or dihydrolipoyl acylglycerides.
    Laszlo JA; Evans KO; Compton DL
    J Liposome Res; 2014 Dec; 24(4):304-12. PubMed ID: 24646435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical liposomal system for localized and controlled drug delivery.
    Singh R; Vyas SP
    J Dermatol Sci; 1996 Nov; 13(2):107-11. PubMed ID: 8953409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanodelivery Systems for Topical Management of Skin Disorders.
    Cui M; Wiraja C; Chew SWT; Xu C
    Mol Pharm; 2021 Feb; 18(2):491-505. PubMed ID: 32470311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liposome encapsulation of a photochemical NO precursor for controlled nitric oxide release and simultaneous fluorescence imaging.
    Ostrowski AD; Lin BF; Tirrell MV; Ford PC
    Mol Pharm; 2012 Oct; 9(10):2950-5. PubMed ID: 22953784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical delivery of liposomally encapsulated gamma-interferon.
    du Plessis J; Egbaria K; Ramachandran C; Weiner N
    Antiviral Res; 1992 Jun; 18(3-4):259-65. PubMed ID: 1416907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for the phagocytosis of intact oligolamellar liposomes by human keratinocytes in vitro and consecutive intracellular disintegration.
    Korting HC; Schmid MH; Hartinger A; Maierhofer G; Stolz W; Braun-Falco O
    J Microencapsul; 1993; 10(2):223-8. PubMed ID: 8331495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical liposome drugs to come: what the patent literature tells us. A review.
    Korting HC; Blecher P; Schäfer-Korting M; Wendel A
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1068-71. PubMed ID: 1810984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reconstructed human skin as model for liposome-skin interaction.
    Zellmer S; Reissig D; Lasch J
    J Control Release; 1998 Nov; 55(2-3):271-9. PubMed ID: 9795080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transdermal absorption of a liposome-encapsulated formulation of lidocaine following topical administration in cats.
    Fransson BA; Peck KE; Smith JK; Anthony JA; Mealey KL
    Am J Vet Res; 2002 Sep; 63(9):1309-12. PubMed ID: 12224866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Recent Overview on Dermatological Applications of Liposomes.
    Kushwaha P; Saxena S; Shukla B
    Recent Pat Nanotechnol; 2021; 15(4):310-321. PubMed ID: 33087038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liposome preparations: a step forward in topical drug therapy for skin disease? A review.
    Schäfer-Korting M; Korting HC; Braun-Falco O
    J Am Acad Dermatol; 1989 Dec; 21(6):1271-5. PubMed ID: 2685061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Encapsulation of drugs and excipients in liposomes--measurements with drug-specific electrodes.
    Gücer N; Ebel J; Gröning R
    Pharm Acta Helv; 1993 Sep; 68(2):129-33. PubMed ID: 8234390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absorption of liposome-encapsulated tetracaine versus nonliposome-encapsulated tetracaine from open wounds in rabbits.
    Fisher R; Murphy M; Hung O; Mezei M; Stewart R
    Am J Emerg Med; 1994 Sep; 12(5):521-3. PubMed ID: 8060403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The parenteral controlled release of liposome encapsulated chloroquine in mice.
    Titulaer HA; Eling WM; Crommelin DJ; Peeters PA; Zuidema J
    J Pharm Pharmacol; 1990 Aug; 42(8):529-32. PubMed ID: 1981577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Compounding is still appropriate in clinical practice.
    Thiers BH
    Dermatol Clin; 1998 Apr; 16(2):329-30. PubMed ID: 9589206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-vivo studies in the treatment of oral ulcers with liposomal dexamethasone sodium phosphate.
    Farshi FS; Ozer AY; Ercan MT; Hincal AA
    J Microencapsul; 1996; 13(5):537-44. PubMed ID: 8864991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Encapsulation of Lidocaine nanoparticles in Gadus morhua derived lipoic acid.
    Anand V; Ramadoss R; Purushothaman B; Sundar S; Panneer Selvam S; Ramani P; Krishna Naik V
    J Oral Biol Craniofac Res; 2023; 13(6):791-795. PubMed ID: 38028227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.